Citation: N. Marx et al., Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?, J CARD RISK, 8(4), 2001, pp. 203-210
Authors:
Marx, N
Mackman, N
Schonbeck, U
Yilmaz, N
Hombach, V
Libby, P
Plutzky, J
Citation: N. Marx et al., PPAR alpha activators inhibit tissue factor expression and activity in human monocytes, CIRCULATION, 103(2), 2001, pp. 213-219
Authors:
Marx, N
Mach, F
Sauty, A
Leung, JH
Sarafi, MN
Ransohoff, RM
Libby, P
Plutzky, J
Luster, AD
Citation: N. Marx et al., Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells, J IMMUNOL, 164(12), 2000, pp. 6503-6508
Citation: H. Ginsberg et al., A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering, J CARD RISK, 6(5), 1999, pp. 337-346
Authors:
Marx, N
Bourcier, T
Sukhova, GK
Libby, P
Plutzky, J
Citation: N. Marx et al., PPAR gamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression - PPAR gamma as a potential mediator in vascular disease, ART THROM V, 19(3), 1999, pp. 546-551
Authors:
Marx, N
Sukhova, GK
Collins, T
Libby, P
Plutzky, J
Citation: N. Marx et al., PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells, CIRCULATION, 99(24), 1999, pp. 3125-3131